Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Inventory (2020 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Inventory came in at $125000.0 in Q2 2026, up 12475.45% year-over-year from N/an in Q2 2025, and little changed quarter-over-quarter from $125000.0 in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Inventory (2020 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Inventory for 7 consecutive years, with $125000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Inventory rose 12475.45% year-over-year to $125000.0 in Q2 2026; TTM through Jun 2026 was $125000.0, a 12475.45% increase from a year earlier, with the FY2024 full-year figure at $2194.0, down 66.73% from the prior year.
  • Inventory was $125000.0 for Q2 2026 at Creative Medical Technology Holdings, roughly flat from $125000.0 in the prior quarter.
  • Over five years, Inventory peaked at $125000.0 in Q1 2026 and troughed at $994.0 in Q1 2025.
  • A 5-year average of $21423.4 and a median of $7794.0 in 2023 frame the typical range for Inventory.
  • Across the five-year window, Inventory tumbled 84.93% in 2025 and soared 12475.45% in 2026, its largest moves.
  • Over 5 years, Inventory stood at $10194.0 in 2022, then tumbled by 35.31% to $6594.0 in 2023, then slumped by 66.73% to $2194.0 in 2024, then slumped by 54.69% to $994.0 in 2025, then soared by 12475.45% to $125000.0 in 2026.
  • The last three Inventory figures came in at $125000.0 (Q2 2026), $125000.0 (Q1 2026), and $994.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 45.56 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 55.59 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 41.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn -
6 Beam Therapeutics 3.06 Bn 3.06 Bn - -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 20.25 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 904.27 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 18.38 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 125,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125,000.00
Mar 31, 2026 125,000.00
Sep 30, 2025 994.00
Jun 30, 2025 994.00
Mar 31, 2025 994.00
Dec 31, 2024 2,194.00
Sep 30, 2024 3,394.00
Jun 30, 2024 3,394.00
Mar 31, 2024 6,594.00
Dec 31, 2023 6,594.00
Sep 30, 2023 7,794.00
Jun 30, 2023 10,194.00
Mar 31, 2023 10,194.00
Dec 31, 2022 10,194.00
Sep 30, 2022 15,894.00
Jun 30, 2022 20,625.00
Mar 31, 2022 14,150.00
Dec 31, 2021 10,866.00
Jun 30, 2020 1,200.00
Mar 31, 2020 2,800.00